绥美凯是医保药吗？

It is a drug for the treatment of AIDS. It is currently the only three-in-one compound drug containing dolutegravir (DTG). It has the characteristics of good tolerance, high resistance barrier and few drug interactions. One tablet per day can significantly reduce the medication burden of AIDS patients, thereby improving patients' medication compliance and significantly improving their quality of life. 

Suimeikai has been approved in more than 100 countries and recommended by many authoritative academic institutions in Europe and the United States as a first-line treatment drug for newly treated AIDS patients. 

In January 2018, Suimeikai officially entered the Chinese market. According to Medical Companion Travel, because Suimeikan is an imported original drug in China, it is very expensive and most patients cannot afford it. Therefore, many patients want to know whether Suimeike is a medically insured drug?

It is reported that Suimeikai has not been included in domestic medical insurance and is a self-pay drug for patients. In fact, patients can choose Suimeikai, which is available in India. Suimeikai, produced by the Indian company Emcure, comes in a box of 30 tablets and sells for about RMB 1,000. The price cannot be determined due to the floating exchange rate. Please consult Medical Travel for the specific price.

In addition, there are many precautions when using Suimeikai. Failure to pay attention to the precautions when using the drug will affect the improvement of the condition to a certain extent. In serious cases, it will cause unnecessary harm to the patient's body. Therefore, it is recommended that you understand the precautions before taking the medication.

Suimeikai has many adverse reactions, so patients should always pay attention to their own conditions during the medication. If they notice any discomfort, they should report it to the doctor.

Side effects: depression, abnormal dreams, headache, dizziness, diarrhea, nausea, fatigue.

Recommended related hot articles: /newsDetail/71949.html